Showing results (101-110 of 258) with videos related to
Sort By:
Pageof 26
Cell Stress & Chaperones|March 15, 2002
Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2Wanping Xu, Edward G Mimnaugh, Jung-Sik Kim, et al.Cell Stress & Chaperones|June 14, 2015
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome AtlasHarvey Schwartz, Brad Scroggins, Abbey Zuehlke, et al.Plos One|November 22, 2011
ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancerFumitaka Koga, Soichiro Yoshida, Manabu Tatokoro, et al.Journal of the National Cancer Institute|October 9, 2012
Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavirJoong Sup Shim, Rajini Rao, Kristin Beebe, et al.Cell Cycle (Georgetown, Tex.)|October 19, 2010
Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinomaCarole Sourbier, Vladimir Valera-Romero, Alessio Giubellino, et al.Cell Cycle (Georgetown, Tex.)|December 3, 2011
Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapySoichiro Yoshida, Fumitaka Koga, Manabu Tatokoro, et al.Cancer Science|July 19, 2008
Azaspirene, a fungal product, inhibits angiogenesis by blocking Raf-1 activationYukihiro Asami, Hideaki Kakeya, Yusuke Komi, et al.Cancer Chemotherapy and Pharmacology|October 23, 2020
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumorsKhanh T Do, Geraldine O'Sullivan Coyne, John L Hays, et al.Molecular Cell|February 18, 2010
Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone functionMehdi Mollapour, Shinji Tsutsumi, Alison C Donnelly, et al.Molecular Cancer Therapeutics|January 7, 2005
Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatmentMona S Jhaveri, Antonina S Rait, Koong-Nah Chung, et al.Pageof 26